RhumbLine Advisers’s ANI Pharmaceuticals ANIP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.74M Buy
41,981
+658
+2% +$42.9K ﹤0.01% 1712
2025
Q1
$2.77M Sell
41,323
-684
-2% -$45.8K ﹤0.01% 1649
2024
Q4
$2.32M Sell
42,007
-203
-0.5% -$11.2K ﹤0.01% 1808
2024
Q3
$2.52M Buy
42,210
+40
+0.1% +$2.39K ﹤0.01% 1783
2024
Q2
$2.69M Buy
42,170
+5,617
+15% +$358K ﹤0.01% 1729
2024
Q1
$2.53M Sell
36,553
-1,396
-4% -$96.5K ﹤0.01% 1786
2023
Q4
$2.09M Sell
37,949
-1,735
-4% -$95.7K ﹤0.01% 1878
2023
Q3
$2.3M Buy
39,684
+4,700
+13% +$273K ﹤0.01% 1786
2023
Q2
$1.88M Buy
34,984
+999
+3% +$53.8K ﹤0.01% 1940
2023
Q1
$1.35M Buy
33,985
+2,382
+8% +$94.6K ﹤0.01% 2004
2022
Q4
$1.27M Buy
31,603
+926
+3% +$37.2K ﹤0.01% 2018
2022
Q3
$986K Buy
30,677
+482
+2% +$15.5K ﹤0.01% 2136
2022
Q2
$896K Buy
30,195
+4,279
+17% +$127K ﹤0.01% 2199
2022
Q1
$728K Buy
25,916
+1,096
+4% +$30.8K ﹤0.01% 2263
2021
Q4
$1.14M Sell
24,820
-6,369
-20% -$294K ﹤0.01% 2152
2021
Q3
$1.02M Sell
31,189
-3,257
-9% -$107K ﹤0.01% 2219
2021
Q2
$1.21M Sell
34,446
-378
-1% -$13.2K ﹤0.01% 2155
2021
Q1
$1.26M Buy
34,824
+1,150
+3% +$41.6K ﹤0.01% 2103
2020
Q4
$978K Buy
33,674
+3,239
+11% +$94.1K ﹤0.01% 2139
2020
Q3
$859K Sell
30,435
-1,363
-4% -$38.5K ﹤0.01% 2050
2020
Q2
$1.03M Buy
31,798
+98
+0.3% +$3.17K ﹤0.01% 2029
2020
Q1
$1.29M Buy
31,700
+746
+2% +$30.4K ﹤0.01% 1767
2019
Q4
$1.91M Buy
30,954
+2,217
+8% +$137K ﹤0.01% 1814
2019
Q3
$2.09M Buy
28,737
+2,221
+8% +$162K ﹤0.01% 1722
2019
Q2
$2.18M Buy
26,516
+2,436
+10% +$200K ﹤0.01% 1690
2019
Q1
$1.7M Sell
24,080
-259
-1% -$18.3K ﹤0.01% 1807
2018
Q4
$1.1M Buy
24,339
+3,642
+18% +$164K ﹤0.01% 1957
2018
Q3
$1.17M Sell
20,697
-1,169
-5% -$66.1K ﹤0.01% 1933
2018
Q2
$1.46M Buy
21,866
+1,399
+7% +$93.5K ﹤0.01% 1839
2018
Q1
$1.19M Buy
20,467
+678
+3% +$39.5K ﹤0.01% 1861
2017
Q4
$1.28M Buy
19,789
+2,807
+17% +$181K ﹤0.01% 1843
2017
Q3
$891K Buy
16,982
+990
+6% +$51.9K ﹤0.01% 2030
2017
Q2
$748K Sell
15,992
-81
-0.5% -$3.79K ﹤0.01% 2104
2017
Q1
$796K Buy
16,073
+3,725
+30% +$184K ﹤0.01% 2027
2016
Q4
$749K Buy
12,348
+1,288
+12% +$78.1K ﹤0.01% 2006
2016
Q3
$734K Buy
11,060
+980
+10% +$65K ﹤0.01% 1987
2016
Q2
$563K Buy
10,080
+194
+2% +$10.8K ﹤0.01% 2125
2016
Q1
$333K Buy
9,886
+100
+1% +$3.37K ﹤0.01% 2475
2015
Q4
$442K Buy
9,786
+670
+7% +$30.3K ﹤0.01% 2316
2015
Q3
$360K Buy
9,116
+196
+2% +$7.74K ﹤0.01% 2437
2015
Q2
$553K Buy
8,920
+10
+0.1% +$620 ﹤0.01% 2258
2015
Q1
$557K Buy
8,910
+2,200
+33% +$138K ﹤0.01% 2236
2014
Q4
$378K Buy
+6,710
New +$378K ﹤0.01% 2442